Literature DB >> 16356747

NO-cGMP signaling in development and stem cells.

Joshua S Krumenacker1, Ferid Murad.   

Abstract

Despite the recognition that the NO-cGMP signaling pathway is involved in so many physiological and pathological events, a clear understanding of many of the functions of this signaling pathway remains elusive. Because of its pleiotropic and often transient actions, its modulation for therapeutic purposes in multiple pathological states is a complex issue. Recent work that combines the areas of developmental and stem cell biology and NO-cGMP signaling in various models may help us elucidate some of these functions and even discover novel actions for this signaling paradigm. This review will discuss some of the recent work in these areas, with additional focus on the nitric oxide receptor, soluble guanylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356747     DOI: 10.1016/j.ymgme.2005.10.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

Review 1.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

2.  Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cell.

Authors:  Natália Aparecida de Paula; Andressa Megumi Niwa; Diogo Campos Vesenick; Carolina Panis; Rubens Cecchini; Angelo de Fátima; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

Review 3.  Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells.

Authors:  Amparo Beltran-Povea; Estefania Caballano-Infantes; Carmen Salguero-Aranda; Franz Martín; Bernat Soria; Francisco J Bedoya; Juan R Tejedo; Gladys M Cahuana
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

4.  Low nitric oxide: a key factor underlying copper-deficiency teratogenicity.

Authors:  Soo Jin Yang; Carl L Keen; Louise Lanoue; Robert B Rucker; Janet Y Uriu-Adams
Journal:  Free Radic Biol Med       Date:  2007-09-18       Impact factor: 7.376

5.  Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion.

Authors:  Karina Lidianne Alcântara Saraiva; Amanda Karolina Soares E Silva; Maria Inês Wanderley; Araken Almeida De Araújo; José Roberto Botelho De Souza; Christina Alves Peixoto
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

6.  Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death.

Authors:  Brandon M Curtis; Kyle Alexander Leix; Yajing Ji; Richard Samuel Elliot Glaves; David E Ash; Dillip K Mohanty
Journal:  Biochem Biophys Res Commun       Date:  2014-05-27       Impact factor: 3.575

7.  Nitric oxide/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion.

Authors:  Rahul Mittal; Nemani V Prasadarao
Journal:  Cell Microbiol       Date:  2009-09-02       Impact factor: 3.715

Review 8.  Pluripotent Stem Cells and DNA Damage Response to Ionizing Radiations.

Authors:  Kalpana Mujoo; E Brian Butler; Raj K Pandita; Clayton R Hunt; Tej K Pandita
Journal:  Radiat Res       Date:  2016-06-22       Impact factor: 2.841

9.  Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells.

Authors:  Kalpana Mujoo; Vladislav G Sharin; Nathan S Bryan; Joshua S Krumenacker; Courtney Sloan; Shanaz Parveen; Lubov E Nikonoff; Alexander Y Kots; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

Review 10.  Targeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management.

Authors:  Aleksandra Jankovic; Aleksandra Korac; Biljana Buzadzic; Ana Stancic; Vesna Otasevic; Péter Ferdinandy; Andreas Daiber; Bato Korac
Journal:  Br J Pharmacol       Date:  2016-05-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.